Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,140.00
-20.00 (-0.32%)
At close: Sep 11, 2026

KOSDAQ:036480 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8423,4463,6304,3623,8524,395
Short-Term Investments
6,0815,9435,4237,3659,0075,539
Cash & Short-Term Investments
8,9239,3889,05311,72712,8599,935
Cash Growth
-2.94%3.70%-22.80%-8.80%29.44%-1.17%
Accounts Receivable
3,5425,0243,7794,1313,0402,986
Other Receivables
153.73162.58178.67154.12155.3771.96
Receivables
3,6965,1873,9584,2853,1963,058
Inventory
12,71910,55510,48112,49911,64110,614
Prepaid Expenses
122.2197.17106.25171.0735.2632.9
Other Current Assets
23.486.9242.7734.1958.9782.36
Total Current Assets
25,48325,23423,64128,71728,69023,722
Property, Plant & Equipment
28,92929,95031,94432,12433,30335,846
Long-Term Investments
1,3971,1521,3101,4981,2561,327
Other Intangible Assets
353.99354.51354.8356.77354.83356.3
Long-Term Deferred Tax Assets
849.28849.28574.44734.47134.47355.46
Long-Term Deferred Charges
14.8674.17192.79330.08518.86717.28
Other Long-Term Assets
203.71365.08361.62530.37852.47295.71
Total Assets
57,23057,97958,37964,29065,10962,620

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,2031,1271,3181,543977.94768.84
Accrued Expenses
414.9512.87494.15711.532,6412,047
Short-Term Debt
1,5001,5001,0005,3192,000700
Current Portion of Long-Term Debt
2,6144,6257502,1254,3501,500
Current Portion of Leases
105.85223.73257.16152.28140.83175.61
Current Income Taxes Payable
----377.59-
Other Current Liabilities
422.08542.94710.73547.67124.03122.82
Total Current Liabilities
7,2598,5324,53010,39810,6115,315
Long-Term Debt
14,88613,50018,12516,37515,50019,850
Long-Term Leases
90.94129.09295.4340.3638.45126.51
Pension & Post-Retirement Benefits
148.9----194.65
Other Long-Term Liabilities
353.52397.04279.04127.98122.51130.67
Total Liabilities
22,73922,55823,23026,94226,27225,616

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,9001,9001,9001,9001,9001,900
Additional Paid-In Capital
3,0853,0853,0853,0853,0853,085
Retained Earnings
26,34727,27727,00529,20430,69328,859
Comprehensive Income & Other
3,1603,1603,1603,1603,1603,160
Shareholders' Equity
34,49135,42135,14937,34938,83737,004
Total Liabilities & Equity
57,23057,97958,37964,29065,10962,620

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
19,19719,97820,42824,01122,02922,352
Net Cash (Debt)
-10,274-10,589-11,374-12,284-9,170-12,418
Net Cash Growth
------
Net Cash Per Share
--2786.71-2993.19-3232.58-2413.27-3267.79
Filing Date Shares Outstanding
-3.83.83.83.83.8
Total Common Shares Outstanding
-3.83.83.83.83.8
Working Capital
18,22416,70319,11118,31918,07918,407
Book Value Per Share
-9321.449249.839828.5910220.379737.79
Tangible Book Value
34,13735,06734,79536,99238,48336,647
Tangible Book Value Per Share
-9228.159156.479734.7010127.009644.03
Land
2,9822,9822,9822,9822,9825,335
Buildings
15,17315,45716,02616,59617,16717,741
Machinery
10,50411,09512,3229,44910,67910,440
Construction In Progress
74.3574.3574.352,9092,3022,038